{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:27:08Z","timestamp":1793395628822,"version":"4.5.0"},"reference-count":230,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170212"],"award-info":[{"award-number":["82170212"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82370181"],"award-info":[{"award-number":["82370181"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.cyto.2024.156759","type":"journal-article","created":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T17:27:25Z","timestamp":1726594045000},"page":"156759","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Old drug, new use: Recent advances for G-CSF"],"prefix":"10.1016","volume":"184","author":[{"given":"Lun","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.cyto.2024.156759_b0005","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1073\/pnas.56.2.488","article-title":"In vitro control of the development of macrophage and granulocyte colonies","volume":"56","author":"Ichikawa","year":"1966","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.cyto.2024.156759_b0010","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/icb.1966.28","article-title":"The growth of mouse bone marrow cells in vitro","volume":"44","author":"Bradley","year":"1966","journal-title":"Aust. J. Exp. Biol. Med. Sci."},{"issue":"6","key":"10.1016\/j.cyto.2024.156759_b0015","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1158\/2326-6066.CIR-13-0151","article-title":"The colony-stimulating factors and cancer","volume":"1","author":"Metcalf","year":"2013","journal-title":"Cancer Immunol. Res."},{"issue":"14","key":"10.1016\/j.cyto.2024.156759_b0020","doi-asserted-by":"crossref","first-page":"9017","DOI":"10.1016\/S0021-9258(18)32158-6","article-title":"Purification of a factor inducing differentiation in murine myelomonocytic leukemia cells. Identification as granulocyte colony-stimulating factor","volume":"258","author":"Nicola","year":"1983","journal-title":"J. Biol. Chem."},{"issue":"4746","key":"10.1016\/j.cyto.2024.156759_b0025","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1126\/science.2420009","article-title":"Recombinant human granulocyte colony-stimulating factor: effects on normal and leukemic myeloid cells","volume":"232","author":"Souza","year":"1986","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.cyto.2024.156759_b0030","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.cyto.2008.03.002","article-title":"Granulocyte colony-stimulating factor: molecular mechanisms of action during steady state and 'emergency' hematopoiesis","volume":"42","author":"Panopoulos","year":"2008","journal-title":"Cytokine"},{"issue":"Suppl 1","key":"10.1016\/j.cyto.2024.156759_b0035","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1007\/s11523-011-0190-9","article-title":"Presently available biosimilars in hematology-oncology: G-CSF","volume":"7","author":"Gascon","year":"2012","journal-title":"Target Oncol."},{"issue":"12","key":"10.1016\/j.cyto.2024.156759_b0040","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.1073\/pnas.81.12.3765","article-title":"Binding of the differentiation-inducer, granulocyte-colony-stimulating factor, to responsive but not unresponsive leukemic cell lines","volume":"81","author":"Nicola","year":"1984","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"8","key":"10.1016\/j.cyto.2024.156759_b0045","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1172\/JCI23559","article-title":"The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis","volume":"115","author":"Schneider","year":"2005","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.cyto.2024.156759_b0050","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/08977190500055836","article-title":"G-CSF: a key regulator of neutrophil production, but that's not all!","volume":"23","author":"Roberts","year":"2005","journal-title":"Growth Factors"},{"issue":"6206","key":"10.1016\/j.cyto.2024.156759_b0055","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/337471a0","article-title":"Granulocyte- and granulocyte-macrophage-colony stimulating factors induce human endothelial cells to migrate and proliferate","volume":"337","author":"Bussolino","year":"1989","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.cyto.2024.156759_b0060","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/bjc.2013.822","article-title":"G-CSF and G-CSFR are highly expressed in human gastric and colon cancers and promote carcinoma cell proliferation and migration","volume":"110","author":"Morris","year":"2014","journal-title":"Br. J. Cancer"},{"issue":"22","key":"10.1016\/j.cyto.2024.156759_b0065","doi-asserted-by":"crossref","first-page":"8702","DOI":"10.1073\/pnas.87.22.8702","article-title":"Three different mRNAs encoding human granulocyte colony-stimulating factor receptor","volume":"87","author":"Fukunaga","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cyto.2024.156759_b0070","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.2741\/2041","article-title":"The interaction of G-CSF with its receptor","volume":"11","author":"Layton","year":"2006","journal-title":"Front. Biosci."},{"key":"10.1016\/j.cyto.2024.156759_b0075","doi-asserted-by":"crossref","first-page":"800","DOI":"10.2741\/2103","article-title":"Granulocyte colony-stimulating factor and its receptor in normal myeloid cell development, leukemia and related blood cell disorders","volume":"12","author":"Touw","year":"2007","journal-title":"Front. Biosci."},{"key":"10.1016\/j.cyto.2024.156759_b0080","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/7517350","article-title":"Granulocyte colony-stimulating factor and its potential application for skeletal muscle repair and regeneration","volume":"2017","author":"Wright","year":"2017","journal-title":"Mediators Inflamm."},{"issue":"47","key":"10.1016\/j.cyto.2024.156759_b0085","doi-asserted-by":"crossref","first-page":"6724","DOI":"10.1038\/sj.onc.1210757","article-title":"Hematopoietic cytokine receptor signaling","volume":"26","author":"Baker","year":"2007","journal-title":"Oncogene"},{"issue":"12","key":"10.1016\/j.cyto.2024.156759_b0090","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1016\/j.biocel.2009.08.011","article-title":"Granulocyte colony-stimulating factor receptor: stimulating granulopoiesis and much more","volume":"41","author":"Liongue","year":"2009","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"1","key":"10.1016\/j.cyto.2024.156759_b0095","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1182\/blood.V93.1.113","article-title":"Tyrosine-dependent and -independent mechanisms of STAT3 activation by the human granulocyte colony-stimulating factor (G-CSF) receptor are differentially utilized depending on G-CSF concentration","volume":"93","author":"Ward","year":"1999","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.cyto.2024.156759_b0100","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1084\/jem.172.6.1559","article-title":"Expression cloning of a human granulocyte colony-stimulating factor receptor: a structural mosaic of hematopoietin receptor, immunoglobulin, and fibronectin domains","volume":"172","author":"Larsen","year":"1990","journal-title":"J. Exp. Med."},{"issue":"5","key":"10.1016\/j.cyto.2024.156759_b0105","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1038\/leu.2013.321","article-title":"Alternatively spliced, truncated GCSF receptor promotes leukemogenic properties and sensitivity to JAK inhibition","volume":"28","author":"Mehta","year":"2014","journal-title":"Leukemia"},{"issue":"9","key":"10.1016\/j.cyto.2024.156759_b0110","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1073\/pnas.0511264103","article-title":"Homodimeric cross-over structure of the human granulocyte colony-stimulating factor (GCSF) receptor signaling complex","volume":"103","author":"Tamada","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.cyto.2024.156759_b0115","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ejca.2010.10.013","article-title":"2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours","volume":"47","author":"Aapro","year":"2011","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.cyto.2024.156759_b0120","doi-asserted-by":"crossref","unstructured":"T. Arvedson, M.J. Giffin, Structural biology of G-CSF and its receptor. (2012).","DOI":"10.1007\/978-3-0348-0218-5_5"},{"issue":"23","key":"10.1016\/j.cyto.2024.156759_b0125","doi-asserted-by":"crossref","first-page":"7184","DOI":"10.1021\/bi00189a022","article-title":"Secondary structure and backbone dynamics of human granulocyte colony-stimulating factor in solution","volume":"33","author":"Werner","year":"1994","journal-title":"Biochemistry"},{"issue":"8","key":"10.1016\/j.cyto.2024.156759_b0130","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1182\/blood-2005-01-015081","article-title":"Regulation of systemic and local neutrophil responses by G-CSF during pulmonary Pseudomonas aeruginosa infection","volume":"109","author":"Gregory","year":"2007","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.cyto.2024.156759_b0135","doi-asserted-by":"crossref","DOI":"10.3390\/cells7010004","article-title":"Targeting FLT3 mutations in acute myeloid leukemia","volume":"7","author":"El Fakih","year":"2018","journal-title":"Cells"},{"key":"10.1016\/j.cyto.2024.156759_b0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.exphem.2018.07.007","article-title":"Philadelphia-like acute lymphoblastic leukemia: diagnostic dilemma and management perspectives","volume":"67","author":"Kotb","year":"2018","journal-title":"Exp. Hematol."},{"issue":"22","key":"10.1016\/j.cyto.2024.156759_b0145","doi-asserted-by":"crossref","first-page":"5071","DOI":"10.1182\/blood-2012-01-406116","article-title":"Sequential gain of mutations in severe congenital neutropenia progressing to acute myeloid leukemia","volume":"119","author":"Beekman","year":"2012","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.cyto.2024.156759_b0150","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.4049\/jimmunol.1500861","article-title":"G-CSF and GM-CSF in neutropenia","volume":"195","author":"Mehta","year":"2015","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.cyto.2024.156759_b0155","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1182\/blood.V84.6.1737.1737","article-title":"Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization","volume":"84","author":"Lieschke","year":"1994","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.cyto.2024.156759_b0160","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S1074-7613(00)80504-X","article-title":"Impaired production and increased apoptosis of neutrophils in granulocyte colony-stimulating factor receptor-deficient mice","volume":"5","author":"Liu","year":"1996","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.cyto.2024.156759_b0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0091990","article-title":"Hematopoietic properties of granulocyte colony-stimulating factor\/immunoglobulin (G-CSF\/IgG-Fc) fusion proteins in normal and neutropenic rodents","volume":"9","author":"Cox","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.cyto.2024.156759_b0170","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1128\/iai.56.1.247-251.1988","article-title":"Production of colony-stimulating factors (CSFs) during infection: separate determinations of macrophage-, granulocyte-, granulocyte-macrophage-, and multi-CSFs","volume":"56","author":"Cheers","year":"1988","journal-title":"Infect. Immun."},{"issue":"10","key":"10.1016\/j.cyto.2024.156759_b0175","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1182\/blood.V76.10.1962.1962","article-title":"Levels of serum granulocyte colony-stimulating factor in patients with infections","volume":"76","author":"Kawakami","year":"1990","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.cyto.2024.156759_b0180","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1053\/cp.1999.v66.a101210","article-title":"Effect of filgrastim treatment on inflammatory cytokines and lymphocyte functions","volume":"66","author":"Hartung","year":"1999","journal-title":"Clin. Pharmacol. Ther."},{"issue":"10","key":"10.1016\/j.cyto.2024.156759_b0185","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1084\/jem.20160393","article-title":"G-CSF maintains controlled neutrophil mobilization during acute inflammation by negatively regulating CXCR2 signaling","volume":"213","author":"Bajrami","year":"2016","journal-title":"J. Exp. Med."},{"issue":"10","key":"10.1016\/j.cyto.2024.156759_b0190","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1182\/blood.V77.10.2154.2154","article-title":"Myeloid cell kinetics in mice treated with recombinant interleukin-3, granulocyte colony-stimulating factor (CSF), or granulocyte-macrophage CSF in vivo","volume":"77","author":"Lord","year":"1991","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.cyto.2024.156759_b0195","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1182\/blood.V100.3.854","article-title":"Evaluation of role of G-CSF in the production, survival, and release of neutrophils from bone marrow into circulation","volume":"100","author":"Basu","year":"2002","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.cyto.2024.156759_b0200","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1177\/0091270006288731","article-title":"Pharmacokinetic\/pharmacodynamic modeling of pegfilgrastim in healthy subjects","volume":"46","author":"Roskos","year":"2006","journal-title":"J. Clin. Pharmacol."},{"issue":"21","key":"10.1016\/j.cyto.2024.156759_b0205","doi-asserted-by":"crossref","first-page":"19001","DOI":"10.1074\/jbc.M112271200","article-title":"Control of myeloid-specific integrin alpha Mbeta 2 (CD11b\/CD18) expression by cytokines is regulated by Stat3-dependent activation of PU.1","volume":"277","author":"Panopoulos","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.cyto.2024.156759_b0210","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1189\/jlb.0312126","article-title":"G-CSF-activated STAT3 enhances production of the chemokine MIP-2 in bone marrow neutrophils","volume":"92","author":"Nguyen-Jackson","year":"2012","journal-title":"J. Leukoc. Biol."},{"issue":"16","key":"10.1016\/j.cyto.2024.156759_b0215","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1182\/blood-2009-08-240317","article-title":"STAT3 controls the neutrophil migratory response to CXCR2 ligands by direct activation of G-CSF-induced CXCR2 expression and via modulation of CXCR2 signal transduction","volume":"115","author":"Nguyen-Jackson","year":"2010","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.cyto.2024.156759_b0220","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S1040-8428(01)00202-5","article-title":"Peripheral blood stem cell mobilization. A role for CXC chemokines","volume":"43","author":"Pelus","year":"2002","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"5","key":"10.1016\/j.cyto.2024.156759_b0225","first-page":"2019","article-title":"The role of granulocyte colony-stimulating factor in breast cancer development: A review","volume":"21","author":"Liu","year":"2020","journal-title":"Mol. Med. Rep."},{"issue":"4","key":"10.1016\/j.cyto.2024.156759_b0230","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1084\/jem.189.4.683","article-title":"Sustained receptor activation and hyperproliferation in response to granulocyte colony-stimulating factor (G-CSF) in mice with a severe congenital neutropenia\/acute myeloid leukemia-derived mutation in the G-CSF receptor gene","volume":"189","author":"Hermans","year":"1999","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cyto.2024.156759_b0235","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.exphem.2016.10.008","article-title":"Granulocyte colony-stimulating factor receptor signaling in severe congenital neutropenia, chronic neutrophilic leukemia, and related malignancies","volume":"46","author":"Dwivedi","year":"2017","journal-title":"Exp. Hematol."},{"issue":"5","key":"10.1016\/j.cyto.2024.156759_b0240","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1159\/000486681","article-title":"How safe is the administration of long-acting granulocyte colony-stimulating factor in cancer patients?","volume":"41","author":"Geissler","year":"2018","journal-title":"Oncol Res Treat."},{"issue":"2","key":"10.1016\/j.cyto.2024.156759_b0245","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0955-2235(05)80004-3","article-title":"Granulocyte colony-stimulating factor and its receptor","volume":"3","author":"Nagata","year":"1991","journal-title":"Prog. Growth Factor Res."},{"issue":"11","key":"10.1016\/j.cyto.2024.156759_b0250","doi-asserted-by":"crossref","first-page":"4683","DOI":"10.1073\/pnas.91.11.4683","article-title":"Granulocyte colony-stimulating factor receptor signaling involves the formation of a three-component complex with Lyn and Syk protein-tyrosine kinases","volume":"91","author":"Corey","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.cyto.2024.156759_b0255","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2741\/4089","article-title":"Scratching the surface: signaling and routing dynamics of the CSF3 receptor","volume":"18","author":"Palande","year":"2013","journal-title":"Front. Biosci. (Landmark Ed)."},{"issue":"1","key":"10.1016\/j.cyto.2024.156759_b0260","first-page":"72","article-title":"Congenital neutropenias","volume":"7","author":"Zeidler","year":"2003","journal-title":"Rev. Clin. Exp. Hematol."},{"issue":"5","key":"10.1016\/j.cyto.2024.156759_b0265","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S1470-2045(05)70168-6","article-title":"The MAPK signalling pathways and colorectal cancer","volume":"6","author":"Fang","year":"2005","journal-title":"Lancet Oncol."},{"issue":"7","key":"10.1016\/j.cyto.2024.156759_b0270","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1182\/blood-2002-07-2062","article-title":"Signaling mechanisms coupled to tyrosines in the granulocyte colony-stimulating factor receptor orchestrate G-CSF-induced expansion of myeloid progenitor cells","volume":"101","author":"Hermans","year":"2003","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.cyto.2024.156759_b0275","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1189\/jlb.1211591","article-title":"G-CSF activation of AKT is not sufficient to prolong neutrophil survival","volume":"93","author":"Souza","year":"2013","journal-title":"J. Leukoc. Biol."},{"issue":"23","key":"10.1016\/j.cyto.2024.156759_b0280","doi-asserted-by":"crossref","first-page":"6541","DOI":"10.1002\/j.1460-2075.1996.tb01045.x","article-title":"Mechanism of activation of protein kinase B by insulin and IGF-1","volume":"15","author":"Alessi","year":"1996","journal-title":"EMBO J."},{"issue":"6541","key":"10.1016\/j.cyto.2024.156759_b0285","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/376599a0","article-title":"Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction","volume":"376","author":"Burgering","year":"1995","journal-title":"Nature"},{"issue":"23","key":"10.1016\/j.cyto.2024.156759_b0290","doi-asserted-by":"crossref","first-page":"6025","DOI":"10.1111\/j.1742-4658.2007.06116.x","article-title":"G protein-coupled receptor-induced Akt activity in cellular proliferation and apoptosis","volume":"274","author":"New","year":"2007","journal-title":"FEBS J."},{"issue":"1","key":"10.1016\/j.cyto.2024.156759_b0295","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1182\/blood.V91.1.347","article-title":"Impaired induction of the CD28-responsive complex in granulocyte colony-stimulating factor mobilized CD4 T cells","volume":"91","author":"Tanaka","year":"1998","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.cyto.2024.156759_b0300","doi-asserted-by":"crossref","first-page":"7085","DOI":"10.4049\/jimmunol.175.11.7085","article-title":"Granulocyte colony-stimulating factor: a novel mediator of T cell tolerance","volume":"175","author":"Rutella","year":"2005","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.cyto.2024.156759_b0305","first-page":"1517","article-title":"In vivo induction of T-cell hyporesponsiveness and alteration of immunological cells of bone marrow grafts using granulocyte colony-stimulating factor","volume":"89","author":"Jun","year":"2004","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.cyto.2024.156759_b0310","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1182\/blood.V92.1.215.413k10_215_222","article-title":"Production of interleukin-10 by granulocyte colony-stimulating factor-mobilized blood products: a mechanism for monocyte-mediated suppression of T-cell proliferation","volume":"92","author":"Mielcarek","year":"1998","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.cyto.2024.156759_b0315","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1182\/blood.V89.5.1629","article-title":"Suppression of alloantigen-induced T-cell proliferation by CD14+ cells derived from granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells","volume":"89","author":"Mielcarek","year":"1997","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.cyto.2024.156759_b0320","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1182\/blood-2003-11-3870","article-title":"Cytolytic activity and regulatory functions of inhibitory NK cell receptor-expressing T cells expanded from granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells","volume":"104","author":"Tanaka","year":"2004","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.cyto.2024.156759_b0325","doi-asserted-by":"crossref","first-page":"4422","DOI":"10.1182\/blood.V86.12.4422.bloodjournal86124422","article-title":"Pretreatment of donor mice with granulocyte colony-stimulating factor polarizes donor T lymphocytes toward type-2 cytokine production and reduces severity of experimental graft-versus-host disease","volume":"86","author":"Pan","year":"1995","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.cyto.2024.156759_b0330","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1097\/00007890-199708270-00001","article-title":"Cytokine cascades in acute graft-versus-host disease","volume":"64","author":"Krenger","year":"1997","journal-title":"Transplantation"},{"issue":"10","key":"10.1016\/j.cyto.2024.156759_b0335","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1093\/intimm\/6.10.1545","article-title":"Differential ability of Th1 and Th2 T cells to express Fas ligand and to undergo activation-induced cell death","volume":"6","author":"Ramsdell","year":"1994","journal-title":"Int. Immunol."},{"issue":"5","key":"10.1016\/j.cyto.2024.156759_b0340","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.bbmt.2005.01.005","article-title":"Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation","volume":"11","author":"Le Blanc","year":"2005","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"9419","key":"10.1016\/j.cyto.2024.156759_b0345","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/S0140-6736(04)16104-7","article-title":"Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells","volume":"363","author":"Le Blanc","year":"2004","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.cyto.2024.156759_b0350","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1097\/01.tp.0000214462.63943.14","article-title":"Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease","volume":"81","author":"Ringd\u00e9n","year":"2006","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.cyto.2024.156759_b0355","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/sj.leu.2405090","article-title":"The correlation between cotransplantation of mesenchymal stem cells and higher recurrence rate in hematologic malignancy patients: outcome of a pilot clinical study","volume":"22","author":"Ning","year":"2008","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.cyto.2024.156759_b0360","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bbmt.2005.02.001","article-title":"Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients","volume":"11","author":"Lazarus","year":"2005","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"8","key":"10.1016\/j.cyto.2024.156759_b0365","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1038\/sj.leu.2404777","article-title":"Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells","volume":"21","author":"Le Blanc","year":"2007","journal-title":"Leukemia"},{"issue":"7","key":"10.1016\/j.cyto.2024.156759_b0370","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1182\/blood-2007-04-087056","article-title":"Cotransplantation of ex vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation","volume":"110","author":"Ball","year":"2007","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.cyto.2024.156759_b0375","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.scr.2010.04.002","article-title":"G-CSF increases mesenchymal precursor cell numbers in the bone marrow via an indirect mechanism involving osteoclast-mediated bone resorption","volume":"5","author":"Brouard","year":"2010","journal-title":"Stem Cell Res."},{"issue":"11 Suppl","key":"10.1016\/j.cyto.2024.156759_b0380","first-page":"I24","article-title":"Bone marrow derived mesenchymal cell mobilization by granulocyte-colony stimulating factor after acute myocardial infarction: results from the Stem Cells in Myocardial Infarction (STEMMI) trial","volume":"116","author":"Ripa","year":"2007","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.cyto.2024.156759_b0385","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1253\/circj.72.1351","article-title":"Granulocyte-colony stimulating factor increases donor mesenchymal stem cells in bone marrow and their mobilization into peripheral circulation but does not repair dystrophic heart after bone marrow transplantation","volume":"72","author":"Tatsumi","year":"2008","journal-title":"Circ. J."},{"issue":"10","key":"10.1016\/j.cyto.2024.156759_b0390","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1161\/CIRCRESAHA.109.195859","article-title":"Multipotent progenitor cells are present in human peripheral blood","volume":"104","author":"Cesselli","year":"2009","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.cyto.2024.156759_b0395","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/bmt.2011.22","article-title":"G-CSF downregulates natural killer cell-mediated cytotoxicity in donors for hematopoietic SCT","volume":"47","author":"Su","year":"2012","journal-title":"Bone Marrow Transplant."},{"issue":"3","key":"10.1016\/j.cyto.2024.156759_b0400","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1182\/blood-2004-01-0086","article-title":"Large-scale in vitro expansion of polyclonal human CD4(+)CD25 high regulatory T cells","volume":"104","author":"Hoffmann","year":"2004","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.cyto.2024.156759_b0405","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1182\/blood-2003-06-2073","article-title":"Chronic graft-versus-host disease is associated with increased numbers of peripheral blood CD4+CD25 high regulatory T cells","volume":"103","author":"Clark","year":"2004","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.cyto.2024.156759_b0410","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1182\/blood-2007-08-109678","article-title":"Effector memory CD4+ T cells mediate graft-versus-leukemia without inducing graft-versus-host disease","volume":"111","author":"Zheng","year":"2008","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.cyto.2024.156759_b0415","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1182\/blood-2003-08-2987","article-title":"Transfer of allogeneic CD62L- memory T cells without graft-versus-host disease","volume":"103","author":"Chen","year":"2004","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.cyto.2024.156759_b0420","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.transci.2010.05.003","article-title":"Cost and outcome in stem cell collections in HLA-haplo identical\/mismatched related transplantation with combined granulocyte-colony stimulating factor-mobilized blood and bone marrow for patients with hematologic malignancies","volume":"43","author":"Chen","year":"2010","journal-title":"Transfus. Apher. Sci."},{"issue":"1","key":"10.1016\/j.cyto.2024.156759_b0425","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.bcmd.2009.02.005","article-title":"HLA-haploidentical blood and bone marrow transplantation with anti-thymocyte globulin: long-term comparison with HLA-identical sibling transplantation","volume":"43","author":"Chen","year":"2009","journal-title":"Blood Cell Mol. Dis."},{"issue":"3","key":"10.1016\/j.cyto.2024.156759_b0430","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.trim.2006.10.002","article-title":"Maintaining hyporesponsiveness and polarization potential of T cells after in vitro mixture of G-CSF mobilized peripheral blood grafts and G-CSF primed bone marrow grafts in different proportions","volume":"17","author":"Huang","year":"2007","journal-title":"Transpl. Immunol."},{"issue":"12","key":"10.1016\/j.cyto.2024.156759_b0435","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1182\/blood.V83.12.3815.3815","article-title":"In vivo blockade of CD28\/CTLA4: B7\/BB1 interaction with CTLA4-Ig reduces lethal murine graft-versus-host disease across the major histocompatibility complex barrier in mice","volume":"83","author":"Blazar","year":"1994","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.cyto.2024.156759_b0440","doi-asserted-by":"crossref","first-page":"4960","DOI":"10.4049\/jimmunol.173.8.4960","article-title":"Granulocyte colony-stimulating factor modulates alpha-galactosylceramide-responsive human Valpha24+Vbeta11+NKT cells","volume":"173","author":"Crough","year":"2004","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.cyto.2024.156759_b0445","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1084\/jem.189.7.1073","article-title":"Bone marrow NK1.1(-) and NK1.1(+) T cells reciprocally regulate acute graft versus host disease","volume":"189","author":"Zeng","year":"1999","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.cyto.2024.156759_b0450","doi-asserted-by":"crossref","first-page":"373","DOI":"10.4049\/jimmunol.148.2.373","article-title":"Studies of CD4- CD8- alpha beta bone marrow T cells with suppressor activity","volume":"148","author":"Palathumpat","year":"1992","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.cyto.2024.156759_b0455","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1182\/blood.V89.7.2586","article-title":"Granulocyte colony-stimulating factor-induced comobilization of CD4- CD8- T cells and hematopoietic progenitor cells (CD34+) in the blood of normal donors","volume":"89","author":"Kusnierz-Glaz","year":"1997","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.cyto.2024.156759_b0460","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1532\/IJH97.A10227","article-title":"Effect of recombinant human granulocyte colony-stimulating factor on T-lymphocyte function and the mechanism of this effect","volume":"79","author":"Chen","year":"2004","journal-title":"Int. J. Hematol."},{"issue":"1","key":"10.1016\/j.cyto.2024.156759_b0465","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s12964-023-01191-4","article-title":"The role of MSCs and CAR-MSCs in cellular immunotherapy","volume":"21","author":"Yan","year":"2023","journal-title":"Cell Commun. Signal"},{"issue":"10","key":"10.1016\/j.cyto.2024.156759_b0470","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1016\/j.bbmt.2016.06.024","article-title":"Hematopoietic, mesenchymal, and immune cells are more enhanced in bone marrow than in peripheral blood from granulocyte colony-stimulating factor primed healthy donors","volume":"22","author":"De Felice","year":"2016","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"1","key":"10.1016\/j.cyto.2024.156759_b0475","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s13287-018-0877-2","article-title":"Different effects of granulocyte colony-stimulating factor and erythropoietin on erythropoiesis","volume":"9","author":"Chen","year":"2018","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"10.1016\/j.cyto.2024.156759_b0480","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12929-019-0597-7","article-title":"Mode of action of granulocyte-colony stimulating factor (G-CSF) as a novel therapy for stroke in a mouse model","volume":"27","author":"Modi","year":"2020","journal-title":"J. Biomed. Sci."},{"issue":"25","key":"10.1016\/j.cyto.2024.156759_b0485","first-page":"77","article-title":"Chemotherapy-induced febrile neutropenia in solid tumours","volume":"1","author":"Rasmy","year":"2017","journal-title":"Gulf J. Oncolog."},{"issue":"31","key":"10.1016\/j.cyto.2024.156759_b0490","doi-asserted-by":"crossref","first-page":"7974","DOI":"10.1200\/JCO.2004.00.7955","article-title":"Prevention of chemotherapy-induced febrile neutropenia by prophylactic antibiotics plus or minus granulocyte colony-stimulating factor in small-cell lung cancer: a Dutch Randomized Phase III Study","volume":"23","author":"Timmer-Bonte","year":"2005","journal-title":"J. Clin. Oncol."},{"issue":"21","key":"10.1016\/j.cyto.2024.156759_b0495","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1200\/JCO.2006.08.8823","article-title":"Impact of primary prophylaxis with granulocyte colony-stimulating factor on febrile neutropenia and mortality in adult cancer patients receiving chemotherapy: a systematic review","volume":"25","author":"Kuderer","year":"2007","journal-title":"J. Clin. Oncol."},{"issue":"18","key":"10.1016\/j.cyto.2024.156759_b0500","doi-asserted-by":"crossref","first-page":"4198","DOI":"10.1200\/JCO.2005.05.645","article-title":"Colony-stimulating factors for chemotherapy-induced febrile neutropenia: a meta-analysis of randomized controlled trials","volume":"23","author":"Clark","year":"2005","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.cyto.2024.156759_b0505","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/jnci\/93.1.31","article-title":"Granulocyte colony-stimulating factor in the treatment of high-risk febrile neutropenia: a multicenter randomized trial","volume":"93","author":"Garc\u00eda-Carbonero","year":"2001","journal-title":"J. Natl Cancer Inst."},{"issue":"2","key":"10.1016\/j.cyto.2024.156759_b0510","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/bmt.2010.112","article-title":"Blood stream infection (BSI) and acute GVHD after hematopoietic SCT (HSCT) are associated","volume":"46","author":"Poutsiaka","year":"2011","journal-title":"Bone Marrow Transplant."},{"issue":"12","key":"10.1016\/j.cyto.2024.156759_b0515","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1038\/bmt.2013.103","article-title":"Pre-engraftment blood stream infection is a risk factor for acute GVHD grades II-IV","volume":"48","author":"Blennow","year":"2013","journal-title":"Bone Marrow Transplant."},{"issue":"1","key":"10.1016\/j.cyto.2024.156759_b0520","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.bbmt.2008.10.024","article-title":"Blood stream infections in allogeneic hematopoietic stem cell transplant recipients: reemergence of Gram-negative rods and increasing antibiotic resistance","volume":"15","author":"Mikulska","year":"2009","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"5","key":"10.1016\/j.cyto.2024.156759_b0525","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s10096-019-03482-6","article-title":"G-CSF-primed haplo-identical HSCT with intensive immunosuppressive and myelosuppressive treatments does not increase the risk of pre-engraftment bloodstream infection: a multicenter case-control study","volume":"38","author":"Ren","year":"2019","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"issue":"12","key":"10.1016\/j.cyto.2024.156759_b0530","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.23592","article-title":"G-CSF as a potential early biomarker for diagnosis of bloodstream infection","volume":"35","author":"Li","year":"2021","journal-title":"J. Clin. Lab. Anal."},{"issue":"2","key":"10.1016\/j.cyto.2024.156759_b0535","first-page":"749","article-title":"[The plasma levels of granulocyte-colony stimulating factor (G-CSF) and macrophage-colony stimulating factor (M-CSF) in breast cancer patients]","volume":"116","author":"Lawicki","year":"2006","journal-title":"Pol. Arch. Med. Wewn."},{"issue":"1","key":"10.1016\/j.cyto.2024.156759_b0540","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.cyto.2011.03.002","article-title":"H-Ras-specific upregulation of granulocyte colony-stimulating factor promotes human breast cell invasion via matrix metalloproteinase-2","volume":"55","author":"Park","year":"2011","journal-title":"Cytokine"},{"issue":"3","key":"10.1016\/j.cyto.2024.156759_b0545","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.4049\/jimmunol.1001965","article-title":"GM-CSF production by glioblastoma cells has a functional role in eosinophil survival, activation, and growth factor production for enhanced tumor cell proliferation","volume":"187","author":"Curran","year":"2011","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.cyto.2024.156759_b0550","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1093\/neuonc\/nor042","article-title":"Myeloid-derived suppressor cell accumulation and function in patients with newly diagnosed glioblastoma","volume":"13","author":"Raychaudhuri","year":"2011","journal-title":"Neuro Oncol."},{"issue":"3","key":"10.1016\/j.cyto.2024.156759_b0555","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/ijc.23986","article-title":"Cure of established GL261 mouse gliomas after combined immunotherapy with GM-CSF and IFNgamma is mediated by both CD8+ and CD4+ T-cells","volume":"124","author":"Smith","year":"2009","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.cyto.2024.156759_b0560","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/ijc.22286","article-title":"Synergism between GM-CSF and IFNgamma: enhanced immunotherapy in mice with glioma","volume":"120","author":"Smith","year":"2007","journal-title":"Int. J. Cancer"},{"issue":"2","key":"10.1016\/j.cyto.2024.156759_b0565","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0169-5002(02)00082-X","article-title":"Role of granulocyte and granulocyte-macrophage colony-stimulating factors in the treatment of small-cell lung cancer: a systematic review of the literature with methodological assessment and meta-analysis","volume":"37","author":"Berghmans","year":"2002","journal-title":"Lung Cancer"},{"issue":"11","key":"10.1016\/j.cyto.2024.156759_b0570","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1007\/s00595-008-3941-1","article-title":"Aggressive undifferentiated colon carcinoma producing granulocyte-colony stimulating factor: report of a case","volume":"39","author":"Matsuda","year":"2009","journal-title":"Surg. Today"},{"issue":"2","key":"10.1016\/j.cyto.2024.156759_b0575","first-page":"79","article-title":"Granulocyte colony-stimulating factor-producing ascending colon cancer as indicated by histopathological findings: report of a case","volume":"57","author":"Fujiwara","year":"2011","journal-title":"Osaka City Med. J."},{"issue":"7","key":"10.1016\/j.cyto.2024.156759_b0580","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1097\/MPA.0b013e318258055c","article-title":"Japan Pancreatic Cancer Registry; 30th year anniversary: Japan Pancreas Society","volume":"41","author":"Egawa","year":"2012","journal-title":"Pancreas"},{"key":"10.1016\/j.cyto.2024.156759_b0585","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.2147\/CMAR.S165226","article-title":"G-CSF associates with neurogenesis and predicts prognosis and sensitivity to chemotherapy in pancreatic ductal adenocarcinoma","volume":"10","author":"Zhang","year":"2018","journal-title":"Cancer Manag. Res."},{"issue":"6","key":"10.1016\/j.cyto.2024.156759_b0590","first-page":"2237","article-title":"Evaluation of pro- and anti-tumor effects induced by three colony-stimulating factors, G-CSF, GM-CSF and M-CSF, in bladder cancer cells: Is G-CSF a friend of bladder cancer cells?","volume":"54","author":"Hori","year":"2019","journal-title":"Int. J. Oncol."},{"issue":"4","key":"10.1016\/j.cyto.2024.156759_b0595","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1097\/CMR.0b013e328339da1e","article-title":"Paraneoplastic granulocytosis in metastatic melanoma","volume":"20","author":"Davis","year":"2010","journal-title":"Melanoma Res."},{"issue":"1","key":"10.1016\/j.cyto.2024.156759_b0600","doi-asserted-by":"crossref","first-page":"23","DOI":"10.4161\/cbt.4.1.1447","article-title":"Paraneoplastic leukemoid reaction and rapid progression in a patient with malignant melanoma: establishment of KT293, a novel G-CSF-secreting melanoma cell line","volume":"4","author":"Schniewind","year":"2005","journal-title":"Cancer Biol. Ther."},{"issue":"3","key":"10.1016\/j.cyto.2024.156759_b0605","doi-asserted-by":"crossref","first-page":"219","DOI":"10.5045\/kjh.2012.47.3.219","article-title":"Effects of granulocyte-colony stimulating factor and the expression of its receptor on various malignant cells","volume":"47","author":"Moon","year":"2012","journal-title":"Korean J Hematol."},{"issue":"3","key":"10.1016\/j.cyto.2024.156759_b0610","first-page":"38","article-title":"Acute myeloid leukemia: a review","volume":"103","author":"Pelcovits","year":"2020","journal-title":"R. I. Med. J. (2013)"},{"issue":"7","key":"10.1016\/j.cyto.2024.156759_b0615","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1182\/blood.V92.7.2322","article-title":"The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties","volume":"92","author":"Grimwade","year":"1998","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.cyto.2024.156759_b0620","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1200\/JCO.2010.30.1820","article-title":"Therapeutic advances in acute myeloid leukemia","volume":"29","author":"Burnett","year":"2011","journal-title":"J. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.cyto.2024.156759_b0625","first-page":"810","article-title":"Effect of recombinant GM-CSF on the metabolism of cytosine arabinoside in normal and leukemic human bone marrow cells","volume":"2","author":"Bhalla","year":"1988","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.cyto.2024.156759_b0630","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1182\/blood.V73.5.1272.bloodjournal7351272","article-title":"Growth factors influence the sensitivity of leukemic stem cells to cytosine arabinoside in culture","volume":"73","author":"Miyauchi","year":"1989","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.cyto.2024.156759_b0635","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ctrv.2006.03.002","article-title":"Prophylactic colony-stimulating factors in children receiving myelosuppressive chemotherapy: a meta-analysis of randomized controlled trials","volume":"32","author":"Wittman","year":"2006","journal-title":"Cancer Treat. Rev."},{"issue":"15","key":"10.1016\/j.cyto.2024.156759_b0640","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1016\/j.ejca.2006.05.002","article-title":"EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours","volume":"42","author":"Aapro","year":"2006","journal-title":"Eur. J. Cancer"},{"issue":"19","key":"10.1016\/j.cyto.2024.156759_b0645","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1200\/JCO.2006.06.4451","article-title":"2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline","volume":"24","author":"Smith","year":"2006","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.cyto.2024.156759_b0650","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1182\/blood.V69.6.1771.1771","article-title":"The effects of GM-CSF and G-CSF in promoting growth of clonogenic cells in acute myeloblastic leukemia","volume":"69","author":"Vellenga","year":"1987","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.cyto.2024.156759_b0655","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1182\/blood.V81.2.281.281","article-title":"Hematopoietic growth factors and their receptors in acute leukemia","volume":"81","author":"L\u00f6wenberg","year":"1993","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.cyto.2024.156759_b0660","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/bmt.2014.64","article-title":"Use of G-CSF to hasten neutrophil recovery after auto-SCT for AML is not associated with increased relapse incidence: a report from the Acute Leukemia Working Party of the EBMT","volume":"49","author":"Czerw","year":"2014","journal-title":"Bone Marrow Transplant."},{"issue":"9","key":"10.1016\/j.cyto.2024.156759_b0665","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1080\/10245332.2018.1446811","article-title":"Impact on acute myeloid leukemia relapse in granulocyte colony-stimulating factor application: a meta-analysis","volume":"23","author":"Feng","year":"2018","journal-title":"Hematology"},{"issue":"6","key":"10.1016\/j.cyto.2024.156759_b0670","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1038\/leu.2016.25","article-title":"Increasing intensity of therapies assigned at diagnosis does not improve survival of adults with acute myeloid leukemia","volume":"30","author":"Krug","year":"2016","journal-title":"Leukemia"},{"issue":"12","key":"10.1016\/j.cyto.2024.156759_b0675","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.bbmt.2014.08.001","volume":"20","author":"Gao","year":"2014","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"23","key":"10.1016\/j.cyto.2024.156759_b0680","doi-asserted-by":"crossref","first-page":"5367","DOI":"10.1182\/blood-2011-11-389841","article-title":"Favorable effect of priming with granulocyte colony-stimulating factor in remission induction of acute myeloid leukemia restricted to dose escalation of cytarabine","volume":"119","author":"Pabst","year":"2012","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.cyto.2024.156759_b0685","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.leukres.2010.07.005","article-title":"Short and long term effects of granulocyte colony-stimulating factor during induction therapy in acute myeloid leukemia patients younger than 65: results of a randomized multicenter phase III trial","volume":"35","author":"Beksac","year":"2011","journal-title":"Leuk. Res."},{"issue":"12","key":"10.1016\/j.cyto.2024.156759_b0690","doi-asserted-by":"crossref","first-page":"4614","DOI":"10.1182\/blood-2005-10-4202","article-title":"Fludarabine and cytosine are less effective than standard ADE chemotherapy in high-risk acute myeloid leukemia, and addition of G-CSF and ATRA are not beneficial: results of the MRC AML-HR randomized trial","volume":"107","author":"Milligan","year":"2006","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.cyto.2024.156759_b0695","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1056\/NEJMoa025406","article-title":"Effect of priming with granulocyte colony-stimulating factor on the outcome of chemotherapy for acute myeloid leukemia","volume":"349","author":"L\u00f6wenberg","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.cyto.2024.156759_b0700","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s002770050425","volume":"77","author":"Kern","year":"1998","journal-title":"Ann. Hematol."},{"issue":"8","key":"10.1016\/j.cyto.2024.156759_b0705","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1038\/sj.leu.2401474","volume":"13","author":"Thomas","year":"1999","journal-title":"Leukemia"},{"issue":"5\u20136","key":"10.1016\/j.cyto.2024.156759_b0710","doi-asserted-by":"crossref","first-page":"589","DOI":"10.3109\/10428199709050894","article-title":"A pilot study of continuous infusion Ara-C in combination with rhG-CSF in relapsed childhood acute myeloid leukemia","volume":"26","author":"Laver","year":"1997","journal-title":"Leuk. Lymphoma"},{"issue":"1","key":"10.1016\/j.cyto.2024.156759_b0715","first-page":"3","article-title":"GM-CSF in a double-blind randomized, placebo controlled trial in therapy of adult patients with de novo acute myeloid leukemia (AML)","volume":"9","author":"Heil","year":"1995","journal-title":"Leukemia"},{"issue":"9","key":"10.1016\/j.cyto.2024.156759_b0720","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1182\/blood.V79.9.2246.2246","article-title":"Treatment of newly diagnosed acute myelogenous leukemia with granulocyte-macrophage colony-stimulating factor (GM-CSF) before and during continuous-infusion high-dose ara-C + daunorubicin: comparison to patients treated without GM-CSF","volume":"79","author":"Estey","year":"1992","journal-title":"Blood"},{"issue":"Suppl 1","key":"10.1016\/j.cyto.2024.156759_b0725","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1038\/sj.thj.6200392","article-title":"Use of fludarabine in the treatment of acute myeloid leukemia","volume":"5","author":"Jackson","year":"2004","journal-title":"Hematol. J."},{"issue":"6\u20137","key":"10.1016\/j.cyto.2024.156759_b0730","first-page":"323","article-title":"Re-induction with L-DNR\/FLAG improves response after AML relapse, but not long-term survival","volume":"226","author":"Creutzig","year":"2014","journal-title":"Klin. Padiatr."},{"issue":"5","key":"10.1016\/j.cyto.2024.156759_b0735","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/01.mjt.0000181690.21601.09","article-title":"IDA-FLAG regimen for the therapy of primary refractory and relapse acute leukemia: a single-center experience","volume":"13","author":"Yavuz","year":"2006","journal-title":"Am. J. Ther."},{"issue":"1","key":"10.1016\/j.cyto.2024.156759_b0740","first-page":"10","article-title":"Concurrent use of granulocyte colony-stimulating factor with low-dose cytosine arabinoside and aclarubicin for previously treated acute myelogenous leukemia: a pilot study","volume":"9","author":"Yamada","year":"1995","journal-title":"Leukemia"},{"key":"10.1016\/j.cyto.2024.156759_b0745","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1756-8722-4-46","article-title":"A meta-analysis of CAG (cytarabine, aclarubicin, G-CSF) regimen for the treatment of 1029 patients with acute myeloid leukemia and myelodysplastic syndrome","volume":"4","author":"Wei","year":"2011","journal-title":"J. Hematol. Oncol."},{"issue":"3","key":"10.1016\/j.cyto.2024.156759_b0750","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3747\/co.26.5033","article-title":"A general practitioner's guide to hematopoietic stem-cell transplantation","volume":"26","author":"Bazinet","year":"2019","journal-title":"Curr. Oncol."},{"issue":"7","key":"10.1016\/j.cyto.2024.156759_b0755","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1182\/bloodadvances.2018028662","article-title":"Racial disparities in access to HLA-matched unrelated donor transplants: a prospective 1312-patient analysis","volume":"3","author":"Barker","year":"2019","journal-title":"Blood Adv."},{"issue":"4","key":"10.1016\/j.cyto.2024.156759_b0760","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1182\/blood-2013-02-453175","article-title":"Umbilical cord blood transplantation: the first 25 years and beyond","volume":"122","author":"Ballen","year":"2013","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.cyto.2024.156759_b0765","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1182\/blood.2019001212","article-title":"Selection of unrelated donors and cord blood units for hematopoietic cell transplantation: guidelines from the NMDP\/CIBMTR","volume":"134","author":"Dehn","year":"2019","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.cyto.2024.156759_b0770","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.3324\/haematol.2016.149427","article-title":"Comparison of graft-versus-host disease-free, relapse-free survival according to a variety of graft sources: antithymocyte globulin and single cord blood provide favorable outcomes in some subgroups","volume":"101","author":"Inamoto","year":"2016","journal-title":"Haematologica"},{"issue":"9","key":"10.1016\/j.cyto.2024.156759_b0775","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1182\/bloodadvances.2018030171","article-title":"GRFS and CRFS in alternative donor hematopoietic cell transplantation for pediatric patients with acute leukemia","volume":"3","author":"Mehta","year":"2019","journal-title":"Blood Adv."},{"issue":"12","key":"10.1016\/j.cyto.2024.156759_b0780","first-page":"826","article-title":"Kinetic rationale for cytokine-induced recruitment of myeloblastic leukemia followed by cycle-specific chemotherapy in vitro","volume":"4","author":"Tafuri","year":"1990","journal-title":"Leukemia"},{"issue":"12","key":"10.1016\/j.cyto.2024.156759_b0785","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-040467","article-title":"Randomised controlled trial of conditioning regimen for cord blood transplantation for adult myeloid malignancies comparing high-dose cytarabine\/cyclophosphamide\/total body irradiation with versus without G-CSF priming: G-CONCORD study protocol","volume":"10","author":"Terakura","year":"2020","journal-title":"BMJ Open"},{"issue":"3","key":"10.1016\/j.cyto.2024.156759_b0790","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nbt.1607","article-title":"Induction of cell cycle entry eliminates human leukemia stem cells in a mouse model of AML","volume":"28","author":"Saito","year":"2010","journal-title":"Nat. Biotechnol."},{"issue":"1","key":"10.1016\/j.cyto.2024.156759_b0795","doi-asserted-by":"crossref","first-page":"20","DOI":"10.4103\/0366-6999.147790","article-title":"Granulocyte colony-stimulating factor-primed bone marrow: an excellent stem-cell source for transplantation in acute myelocytic leukemia and chronic myelocytic leukemia","volume":"128","author":"Li","year":"2015","journal-title":"Chin Med J (Engl)"},{"issue":"7","key":"10.1016\/j.cyto.2024.156759_b0800","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.bbmt.2013.04.001","article-title":"Allogeneic hematopoietic cell transplantation in first remission abrogates poor outcomes associated with high-risk pediatric acute myeloid leukemia","volume":"19","author":"Burke","year":"2013","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"2","key":"10.1016\/j.cyto.2024.156759_b0805","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1182\/blood-2013-03-491621","article-title":"Results of the AIEOP AML 2002\/01 multicenter prospective trial for the treatment of children with acute myeloid leukemia","volume":"122","author":"Pession","year":"2013","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.cyto.2024.156759_b0810","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/sj.bmt.1705966","article-title":"Haploidentical haematopoietic stem cell transplantation for acute leukaemia in adults: experience in Europe and the United States","volume":"41","author":"Aversa","year":"2008","journal-title":"Bone Marrow Transplant."},{"issue":"7","key":"10.1016\/j.cyto.2024.156759_b0815","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/0145-2126(93)90089-4","article-title":"Recombinant GM-CSF modulates the metabolism of cytosine arabinoside in leukemic cells in bone marrow","volume":"17","author":"Tanaka","year":"1993","journal-title":"Leuk. Res."},{"issue":"5","key":"10.1016\/j.cyto.2024.156759_b0820","first-page":"328","article-title":"Granulocyte-macrophage colony-stimulating factor enhances the cytotoxic effects of cytosine arabinoside in acute myeloblastic leukemia and in the myeloid blast crisis phase of chronic myeloid leukemia","volume":"3","author":"Cannistra","year":"1989","journal-title":"Leukemia"},{"issue":"10","key":"10.1016\/j.cyto.2024.156759_b0825","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1182\/blood.V78.10.2674.2674","article-title":"Treatment with interleukin-3 plus granulocyte-macrophage colony-stimulating factors improves the selectivity of Ara-C in vitro against acute myeloid leukemia blasts","volume":"78","author":"Bhalla","year":"1991","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.cyto.2024.156759_b0830","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1038\/leu.2015.98","article-title":"Comparison of outcomes after unrelated cord blood and unmanipulated haploidentical stem cell transplantation in adults with acute leukemia","volume":"29","author":"Ruggeri","year":"2015","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.cyto.2024.156759_b0835","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.bbmt.2017.12.794","article-title":"Reduced-intensity allogeneic transplant for acute myeloid leukemia and myelodysplastic syndrome using combined CD34-selected haploidentical graft and a single umbilical cord unit compared with matched unrelated donor stem cells in older adults","volume":"24","author":"Tsai","year":"2018","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"1","key":"10.1016\/j.cyto.2024.156759_b0840","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13045-018-0564-x","article-title":"The consensus on indications, conditioning regimen, and donor selection of allogeneic hematopoietic cell transplantation for hematological diseases in China-recommendations from the Chinese Society of Hematology","volume":"11","author":"Xu","year":"2018","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.cyto.2024.156759_b0845","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.canlet.2018.08.030","article-title":"The consensus on the monitoring, treatment, and prevention of leukemia relapse after allogeneic hematopoietic stem cell transplantation in China","volume":"438","author":"Wang","year":"2018","journal-title":"Cancer Lett."},{"issue":"31","key":"10.1016\/j.cyto.2024.156759_b0850","doi-asserted-by":"crossref","first-page":"4938","DOI":"10.1200\/JCO.2007.11.6053","volume":"25","author":"Schmid","year":"2007","journal-title":"J. Clin. Oncol."},{"issue":"36","key":"10.1016\/j.cyto.2024.156759_b0855","doi-asserted-by":"crossref","first-page":"4249","DOI":"10.1200\/JCO.19.03277","article-title":"Effect of rhG-CSF combined with decitabine prophylaxis on relapse of patients with high-risk MRD-negative AML after HSCT: an open-label, multicenter, randomized controlled trial","volume":"38","author":"Gao","year":"2020","journal-title":"J. Clin. Oncol."},{"issue":"14","key":"10.1016\/j.cyto.2024.156759_b0860","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1182\/blood-2011-09-377044","article-title":"Azacitidine augments expansion of regulatory T cells after allogeneic stem cell transplantation in patients with acute myeloid leukemia (AML)","volume":"119","author":"Goodyear","year":"2012","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.cyto.2024.156759_b0865","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.cytogfr.2006.05.002","article-title":"The role of G-CSF in adaptive immunity","volume":"17","author":"Franzke","year":"2006","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.cyto.2024.156759_b0870","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.625165","article-title":"Granulocyte colony-stimulating factor effectively mobilizes TCR \u03b3\u03b4 and NK cells providing an allograft potentially enhanced for the graft-versus-leukemia effect for allogeneic stem cell transplantation","volume":"12","author":"Minculescu","year":"2021","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.cyto.2024.156759_b0875","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1038\/s41409-019-0449-9","article-title":"G-CSF-induced macrophage polarization and mobilization may prevent acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation","volume":"54","author":"Wen","year":"2019","journal-title":"Bone Marrow Transplant."},{"issue":"2","key":"10.1016\/j.cyto.2024.156759_b0880","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s12032-022-01911-9","article-title":"A phase II study of chidamide, cytarabine, aclarubicin, granulocyte colony-stimulating factor, and donor lymphocyte infusion for relapsed acute myeloid leukemia and myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation","volume":"40","author":"Wei","year":"2023","journal-title":"Med. Oncol."},{"issue":"3","key":"10.1016\/j.cyto.2024.156759_b0885","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1016\/S2352-3026(22)00404-5","article-title":"Conditioning regimens for HSCT for patients with high-risk myelodysplastic syndrome and secondary acute myeloid leukaemia","volume":"10","author":"Zhang","year":"2023","journal-title":"Lancet Haematol."},{"key":"10.1016\/j.cyto.2024.156759_b0890","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.blre.2018.09.001","article-title":"Epidemiology of myelodysplastic syndromes: Why characterizing the beast is a prerequisite to taming it","volume":"34","author":"Zeidan","year":"2019","journal-title":"Blood Rev."},{"issue":"6","key":"10.1016\/j.cyto.2024.156759_b0895","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1182\/blood.V89.6.2079","article-title":"International scoring system for evaluating prognosis in myelodysplastic syndromes","volume":"89","author":"Greenberg","year":"1997","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.cyto.2024.156759_b0900","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1182\/blood-2012-03-420489","article-title":"Revised international prognostic scoring system for myelodysplastic syndromes","volume":"120","author":"Greenberg","year":"2012","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.cyto.2024.156759_b0905","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1007\/s11864-022-00965-1","article-title":"New approaches to myelodysplastic syndrome treatment","volume":"23","author":"Bazinet","year":"2022","journal-title":"Curr. Treat. Options Oncol."},{"issue":"17","key":"10.1016\/j.cyto.2024.156759_b0910","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.1200\/JCO.2009.25.8723","article-title":"Acute myeloid leukemia or myelodysplastic syndrome in randomized controlled clinical trials of cancer chemotherapy with granulocyte colony-stimulating factor: a systematic review","volume":"28","author":"Lyman","year":"2010","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.cyto.2024.156759_b0915","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1182\/blood.V77.3.493.bloodjournal773493","article-title":"Differential and synergistic effects of human granulocyte-macrophage colony-stimulating factor and human granulocyte colony-stimulating factor on hematopoiesis in human long-term marrow cultures","volume":"77","author":"Hogge","year":"1991","journal-title":"Blood"},{"issue":"17","key":"10.1016\/j.cyto.2024.156759_b0920","doi-asserted-by":"crossref","first-page":"6291","DOI":"10.1158\/1078-0432.CCR-04-1850","article-title":"Antiapoptotic role of growth factors in the myelodysplastic syndromes: concordance between in vitro and in vivo observations","volume":"11","author":"Tehranchi","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cyto.2024.156759_b0925","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.critrevonc.2019.01.021","article-title":"Efficacy of granulocyte colony stimulating factor in combination with erythropoiesis stimulating agents for treatment of anemia in patients with lower risk myelodysplastic syndromes: A systematic review","volume":"136","author":"Affentranger","year":"2019","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"15","key":"10.1016\/j.cyto.2024.156759_b0930","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1200\/JCO.2010.30.9245","volume":"29","author":"L\u00fcbbert","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.cyto.2024.156759_b0935","doi-asserted-by":"crossref","DOI":"10.1016\/j.leukres.2021.106555","article-title":"A systematic review of higher-risk myelodysplastic syndromes clinical trials to determine the benchmark of azacitidine and explore alternative endpoints for overall survival","volume":"104","author":"Garcia","year":"2021","journal-title":"Leuk. Res."},{"key":"10.1016\/j.cyto.2024.156759_b0940","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.leukres.2016.07.005","article-title":"Effect of granulocyte colony-stimulating factor priming combined with low-dose cytarabine and homoharringtonine in higher risk myelodysplastic syndrome patients","volume":"48","author":"Wang","year":"2016","journal-title":"Leuk. Res."},{"issue":"10","key":"10.1016\/j.cyto.2024.156759_b0945","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0164238","article-title":"HAG (Homoharringtonine, Cytarabine, G-CSF) regimen for the treatment of acute myeloid leukemia and myelodysplastic syndrome: a meta-analysis with 2,314 participants","volume":"11","author":"Xie","year":"2016","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.cyto.2024.156759_b0950","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1136\/archdischild-2016-311251","article-title":"Clinical presentation of childhood leukaemia: a systematic review and meta-analysis","volume":"101","author":"Clarke","year":"2016","journal-title":"Arch. Dis. Child."},{"issue":"2","key":"10.1016\/j.cyto.2024.156759_b0955","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1182\/blood.V82.2.343.343","article-title":"Clinical and biologic relevance of immunologic marker studies in childhood acute lymphoblastic leukemia","volume":"82","author":"Pui","year":"1993","journal-title":"Blood"},{"issue":"9881","key":"10.1016\/j.cyto.2024.156759_b0960","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/S0140-6736(12)62187-4","article-title":"Acute lymphoblastic leukaemia","volume":"381","author":"Inaba","year":"2013","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.cyto.2024.156759_b0965","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.ejca.2011.11.023","article-title":"The prophylactic use of granulocyte-colony stimulating factor during remission induction is associated with increased leukaemia-free survival of adults with acute lymphoblastic leukaemia: a joint analysis of five randomised trials on behalf of the EWALL","volume":"48","author":"Giebel","year":"2012","journal-title":"Eur. J. Cancer"},{"issue":"12","key":"10.1016\/j.cyto.2024.156759_b0970","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1038\/leu.2008.251","article-title":"Factors influencing survival after relapse from acute lymphoblastic leukemia: a Children's Oncology Group study","volume":"22","author":"Nguyen","year":"2008","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.cyto.2024.156759_b0975","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/leu.2009.252","article-title":"Long-term results of St Jude Total Therapy Studies 11, 12, 13A, 13B, and 14 for childhood acute lymphoblastic leukemia","volume":"24","author":"Pui","year":"2010","journal-title":"Leukemia"},{"issue":"10","key":"10.1016\/j.cyto.2024.156759_b0980","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s00277-006-0121-5","article-title":"Fludarabine, cytarabine, and mitoxantrone (FLAM) for the treatment of relapsed and refractory adult acute lymphoblastic leukemia. A phase study by the Polish Adult Leukemia Group (PALG)","volume":"85","author":"Giebel","year":"2006","journal-title":"Ann. Hematol."},{"issue":"23","key":"10.1016\/j.cyto.2024.156759_b0985","doi-asserted-by":"crossref","first-page":"6043","DOI":"10.1182\/blood-2011-08-374710","article-title":"Phase 2 trial of clofarabine in combination with etoposide and cyclophosphamide in pediatric patients with refractory or relapsed acute lymphoblastic leukemia","volume":"118","author":"Hijiya","year":"2011","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.cyto.2024.156759_b0990","doi-asserted-by":"crossref","first-page":"e400","DOI":"10.1038\/bcj.2016.8","article-title":"Efficacy, safety and pharmacokinetics of clofarabine in Chinese pediatric patients with refractory or relapsed acute lymphoblastic leukemia: a phase II, multi-center study","volume":"6","author":"Lu","year":"2016","journal-title":"Blood Cancer J."},{"issue":"4","key":"10.1016\/j.cyto.2024.156759_b0995","doi-asserted-by":"crossref","first-page":"589","DOI":"10.3324\/haematol.2009.014274","article-title":"Outcome after relapse of acute lymphoblastic leukemia in adult patients included in four consecutive risk-adapted trials by the PETHEMA Study Group","volume":"95","author":"Oriol","year":"2010","journal-title":"Haematologica"},{"issue":"12","key":"10.1016\/j.cyto.2024.156759_b1000","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1200\/JCO.2005.03.8554","article-title":"Phase II study of clofarabine in pediatric patients with refractory or relapsed acute lymphoblastic leukemia","volume":"24","author":"Jeha","year":"2006","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.cyto.2024.156759_b1005","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3816\/CLML.2011.n.007","article-title":"Augmented hyper-CVAD based on dose-intensified vincristine, dexamethasone, and asparaginase in adult acute lymphoblastic leukemia salvage therapy","volume":"11","author":"Faderl","year":"2011","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"issue":"23","key":"10.1016\/j.cyto.2024.156759_b1010","doi-asserted-by":"crossref","first-page":"3730","DOI":"10.1200\/JCO.2010.28.8852","article-title":"Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure","volume":"28","author":"Duval","year":"2010","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.cyto.2024.156759_b1015","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1056\/NEJMra052603","article-title":"Treatment of acute lymphoblastic leukemia","volume":"354","author":"Pui","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"25","key":"10.1016\/j.cyto.2024.156759_b1020","doi-asserted-by":"crossref","first-page":"5131","DOI":"10.1182\/blood-2010-01-234120","article-title":"G-CSF and its receptor in myeloid malignancy","volume":"115","author":"Beekman","year":"2010","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.cyto.2024.156759_b1025","doi-asserted-by":"crossref","first-page":"6241","DOI":"10.4049\/jimmunol.1301148","article-title":"Differences in the phenotype, cytokine gene expression profiles, and in vivo alloreactivity of T cells mobilized with plerixafor compared with G-CSF","volume":"191","author":"Lundqvist","year":"2013","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.cyto.2024.156759_b1030","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/hon.2051","article-title":"Low-dose cytarabine and aclarubicin combined with granulocyte colony-stimulating factor for the treatment of relapsed or primary refractory acute lymphocytic leukemia: a retrospective study of 25 Chinese patients","volume":"31","author":"Xue","year":"2013","journal-title":"Hematol. Oncol."},{"key":"10.1016\/j.cyto.2024.156759_b1035","doi-asserted-by":"crossref","DOI":"10.1016\/j.leukres.2015.08.013","article-title":"Efficacy of cytarabine, aclarubicin and granulocyte colony-stimulating factor (CAG) regimen compared to FLAG regimen for adult patients with relapsed\/refractory Philadelphia chromosome-negative acute lymphoblastic leukemia","author":"Li","year":"2015","journal-title":"Leuk. Res."},{"issue":"15","key":"10.1016\/j.cyto.2024.156759_b1040","doi-asserted-by":"crossref","first-page":"5327","DOI":"10.1002\/cam4.3079","article-title":"CAG regimen for refractory or relapsed adult T-cell acute lymphoblastic leukemia: A retrospective, multicenter, cohort study","volume":"9","author":"Qian","year":"2020","journal-title":"Cancer Med."},{"issue":"7","key":"10.1016\/j.cyto.2024.156759_b1045","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1002\/(SICI)1097-0142(19991001)86:7<1203::AID-CNCR15>3.0.CO;2-3","article-title":"Combination therapy with methotrexate, vincristine, polyethylene-glycol conjugated-asparaginase, and prednisone in the treatment of patients with refractory or recurrent acute lymphoblastic leukemia","volume":"86","author":"Aguayo","year":"1999","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.cyto.2024.156759_b1050","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1002\/(SICI)1097-0142(19991001)86:7<1216::AID-CNCR17>3.0.CO;2-O","article-title":"Primary refractory and relapsed adult acute lymphoblastic leukemia: characteristics, treatment results, and prognosis with salvage therapy","volume":"86","author":"Thomas","year":"1999","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.cyto.2024.156759_b1055","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.3324\/haematol.2011.057851","article-title":"High curability via intensive reinduction chemotherapy and stem cell transplantation in young adults with relapsed acute lymphoblastic leukemia in Sweden 2003\u20132007","volume":"97","author":"Kozlowski","year":"2012","journal-title":"Haematologica"},{"key":"10.1016\/j.cyto.2024.156759_b1060","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.leukres.2017.09.016","article-title":"Efficacy and safety of G-CSF, low-dose cytarabine and aclarubicin in combination with l-asparaginase, prednisone in the treatment of refractory or relapsed acute lymphoblastic leukemia","volume":"62","author":"Zhou","year":"2017","journal-title":"Leuk. Res."},{"issue":"1","key":"10.1016\/j.cyto.2024.156759_b1065","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1365-2141.1985.tb07383.x","article-title":"Reactivity of rat monoclonal antibody CAMPATH-1 with human leukaemia cells and its possible application for autologous bone marrow transplantation","volume":"60","author":"Hale","year":"1985","journal-title":"Br. J. Haematol."},{"issue":"7","key":"10.1016\/j.cyto.2024.156759_b1070","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/sj.bmt.1700952","article-title":"Enhancement of megakaryocytopoiesis by Campath-1G-treated natural killer cells","volume":"20","author":"Nagler","year":"1997","journal-title":"Bone Marrow Transplant."},{"issue":"19","key":"10.1016\/j.cyto.2024.156759_b1075","first-page":"6453","article-title":"Effective therapy for a murine model of adult T-cell leukemia with the humanized anti-CD52 monoclonal antibody, Campath-1H","volume":"63","author":"Zhang","year":"2003","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.cyto.2024.156759_b1080","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/ejh.12154","article-title":"Administration of alemtuzumab and G-CSF to adults with relapsed or refractory acute lymphoblastic leukemia: results of a phase II study","volume":"91","author":"Gorin","year":"2013","journal-title":"Eur. J. Haematol."},{"issue":"4","key":"10.1016\/j.cyto.2024.156759_b1085","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.pop.2016.07.012","article-title":"Lymphoma","volume":"43","author":"Mugnaini","year":"2016","journal-title":"Prim. Care"},{"issue":"12","key":"10.1016\/j.cyto.2024.156759_b1090","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1182\/blood-2010-03-276246","article-title":"Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte","volume":"116","author":"Coiffier","year":"2010","journal-title":"Blood"},{"issue":"18","key":"10.1016\/j.cyto.2024.156759_b1095","doi-asserted-by":"crossref","first-page":"4117","DOI":"10.1200\/JCO.2005.09.131","article-title":"Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte","volume":"23","author":"Feugier","year":"2005","journal-title":"J. Clin. Oncol."},{"issue":"19","key":"10.1016\/j.cyto.2024.156759_b1100","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1200\/JCO.2005.05.1003","article-title":"Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma","volume":"24","author":"Habermann","year":"2006","journal-title":"J. Clin. Oncol."},{"issue":"11","key":"10.1016\/j.cyto.2024.156759_b1105","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S1470-2045(11)70235-2","article-title":"CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group","volume":"12","author":"Pfreundschuh","year":"2011","journal-title":"Lancet Oncol."},{"issue":"8","key":"10.1016\/j.cyto.2024.156759_b1110","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2165\/00044011-200929080-00001","article-title":"Implications of the European Organisation for Research And Treatment Of Cancer (EORTC) guidelines on the use of granulocyte colony-stimulating factor (G-CSF) for lymphoma care","volume":"29","author":"Pettengell","year":"2009","journal-title":"Clin. Drug Invest."},{"issue":"3","key":"10.1016\/j.cyto.2024.156759_b1115","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1046\/j.1365-2141.2003.04450.x","article-title":"Impact of granulocyte colony-stimulating factor (CSF) and granulocyte-macrophage CSF in patients with malignant lymphoma: a systematic review","volume":"122","author":"Bohlius","year":"2003","journal-title":"Br. J. Haematol."},{"issue":"17","key":"10.1016\/j.cyto.2024.156759_b1120","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1056\/NEJMra1413485","article-title":"Aplastic Anemia","volume":"379","author":"Young","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.cyto.2024.156759_b1125","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1182\/blood.V79.10.2540.bloodjournal79102540","article-title":"Multicenter randomized study comparing cyclosporine-A alone and antithymocyte globulin with prednisone for treatment of severe aplastic anemia","volume":"79","author":"Gluckman","year":"1992","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.cyto.2024.156759_b1130","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1182\/blood.V77.5.937.937","article-title":"Treatment of aplastic anemia in children with recombinant human granulocyte colony-stimulating factor","volume":"77","author":"Kojima","year":"1991","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.cyto.2024.156759_b1135","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/stem.5530110624","article-title":"Multilineage response in aplastic anemia patients following long-term administration of filgrastim (recombinant human granulocyte colony stimulating factor)","volume":"11","author":"Sonoda","year":"1993","journal-title":"Stem Cells"},{"issue":"5","key":"10.1016\/j.cyto.2024.156759_b1140","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1182\/blood.V85.5.1348.bloodjournal8551348","article-title":"Antilymphocyte globulin, cyclosporin, and granulocyte colony-stimulating factor in patients with acquired severe aplastic anemia (SAA): a pilot study of the EBMT SAA Working Party","volume":"85","author":"Bacigalupo","year":"1995","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.cyto.2024.156759_b1145","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1182\/blood-2006-11-050526","article-title":"Treatment of severe aplastic anemia with antithymocyte globulin and cyclosporin A with or without G-CSF in adults: a multicenter randomized study in Japan","volume":"110","author":"Teramura","year":"2007","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.cyto.2024.156759_b1150","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.transproceed.2020.06.035","article-title":"Transplant in aplastic anemia using combined granulocyte colony-stimulating factor primed blood and bone marrow stem cells: a retrospective analysis","volume":"53","author":"Ali","year":"2021","journal-title":"Transpl. Proc."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466624002631?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466624002631?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T10:31:10Z","timestamp":1778581870000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466624002631"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":230,"alternative-id":["S1043466624002631"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2024.156759","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Old drug, new use: Recent advances for G-CSF","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2024.156759","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"156759"}}